Wire · regulatory
FDA Seeks Feedback on Potential Regulation of GenAI Medical Devices
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 11 September 2026 · Fusion42 review
The FDA is considering new regulatory approaches for generative AI-enabled medical devices to address their unique risks, such as variable outputs and hallucinations, and has requested stakeholder feedback by October 19, 2026.
This Wire brief sits within Fusion42's coverage of Medtech, and 18 sources have reported it between 18 Aug 2026 and 11 Sep 2026.
◆ ◆ The Wire takeaway
You need to prepare for new FDA rules that could reshape how your generative AI medical device is tested and monitored. Engage with the feedback period now to influence regulation and avoid costly compliance surprises.
◆ Coverage
18 sources · first reported 18 Aug 2026 · latest 11 Sep 2026
◆ Topics